載入...
Enhanced Kat3A/Catenin transcription: a common mechanism of therapeutic resistance
Cancers are heterogeneous at the cellular level. Cancer stem cells/tumor initiating cells (CSC/TIC) both initiate tumorigenesis and are responsible for therapeutic resistance and disease relapse. Elimination of CSC/TIC should therefore be able to reverse therapy resistance. In principle, this could...
Na minha lista:
| 發表在: | Cancer Drug Resist |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
OAE Publishing Inc.
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7234864/ https://ncbi.nlm.nih.gov/pubmed/32426696 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.20517/cdr.2019.32 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|